As cannabis legalization continues to spread across the country, major corporations are increasingly taking notice and investing in the industry. In April of 2023, a major beverage company announced a $100 million investment in a cannabis-infused drink startup, signaling the growing trend of large corporations entering the cannabis space.

This is just one example of a recent corporate investment in the cannabis industry. Other notable examples include:

        • In February of 2023, Pfizer, one of the largest pharmaceutical companies in the world, announced a $50 million investment in Oxford Cannabinoid Technologies (OCT), a medical cannabis research firm based in the UK. The investment is aimed at developing new cannabis-based treatments for a range of medical conditions.

        • In March of 2023, Amazon, one of the biggest tech companies globally, announced a partnership with Eaze, a cannabis delivery service in California, with plans to invest $25 million in the company. The partnership aims to streamline the delivery of cannabis products to consumers by leveraging Amazon’s delivery infrastructure and Eaze’s cannabis expertise.

        • In May of 2023, Target, a major retail chain in the US, announced plans to launch a line of CBD products in collaboration with Lord Jones, a cannabis company. The partnership will include a range of products, including CBD-infused beauty and wellness products, such as lotions, balms, and bath products.

        • Altria – In 2018, Altria, the parent company of Marlboro cigarettes, invested $1.8 billion in Canadian cannabis company Cronos Group. This investment gave Altria a 45% stake in Cronos Group and allowed Cronos Group to expand its production and distribution capabilities.

        • Molson Coors Brewing Co. – In 2018, Molson Coors Brewing Co. announced a joint venture with Canadian cannabis company The Hydropothecary Corporation (now known as HEXO Corp) to develop non-alcoholic, cannabis-infused beverages.

        • Coca-Cola – In 2018, it was reported that Coca-Cola was in talks with Canadian cannabis company Aurora Cannabis to develop a line of cannabis-infused beverages. Although a deal was never finalized, this news sent shockwaves through the industry and signaled that major beverage companies were interested in the cannabis space.

        • Anheuser-Busch InBev – In 2018, Anheuser-Busch InBev announced a partnership with Canadian cannabis company Tilray to research and develop cannabis-infused beverages.

    The entry of major corporations has both potential benefits and downsides for the cannabis industry and its consumers. On one hand, it brings legitimacy and increased funding to the industry, helping to break down the stigma that has long surrounded the plant. It can also drive innovation and research, leading to new and improved products that can benefit consumers.

    However, the entry of large corporations could also have negative impacts. The financial resources and distribution networks of large corporations may allow them to dominate the market, squeezing out smaller players and limiting consumer choice. This could ultimately lead to a less diverse and innovative industry, with fewer options for consumers.

    There are also concerns about the potential for large corporations to prioritize profits over public health and safety. As with any industry, there is a risk of cutting corners or taking shortcuts to maximize profits. This could lead to unsafe or low-quality products on the market, putting consumers at risk.

    One potential benefit of large corporations investing in cannabis is the potential to drive down prices, making cannabis more affordable and accessible for consumers. It could also lead to increased research and development, leading to new and improved products that can benefit consumers in a variety of ways.

    Additionally, large corporations entering the cannabis industry may help to reduce the racial disparities that have long existed in the industry. Historically, communities of color have been disproportionately impacted by the War on Drugs, which has led to unequal enforcement of drug laws and unequal access to the legal cannabis industry. The entry of large corporations, particularly those that prioritize diversity and inclusion, could help to create more opportunities for people of color in the industry and help to address these disparities.

    Despite the potential benefits, it is important to approach the entry of large corporations into the cannabis industry with caution. Consumers should be aware of who is behind the products they are purchasing and should seek out products from companies that prioritize transparency, safety, and quality. It is also important to support small, independent businesses that may be at risk of being pushed out of the market by larger corporations.

    Ultimately, the impact of major corporations entering the cannabis space will depend on a variety of factors, including the specific companies involved and their approach to the industry. It will also depend on how the industry as a whole responds to this trend.

    The cannabis industry is rapidly evolving, and it will be interesting to see how this trend continues to develop and what impact it will have on the industry and its consumers. As with any industry, there are both risks and opportunities associated with the entry of large corporations, and it is up to consumers to stay informed and make responsible choices when it comes to their cannabis consumption.


    Revolutionary Shift: US Health Department Proposes Reclassifying Marijuana from Schedule I to Schedule III

    In a groundbreaking move that has the potential to reshape the landscape of cannabis regulations, the U.S. Department of Health and Human Services (HHS) has taken a bold step by formally recommending the reclassification of marijuana from Schedule I to Schedule III under federal law. This historic decision signifies a seismic shift in perspective, indicating that the nation’s premier health agency no longer views cannabis as a substance with high abuse potential and zero medical value.

    New York Expands Legal Cannabis Industry and Cracks Down on Illegal Market

    New York has initiated a major expansion of its legal cannabis industry by opening applications for hundreds of new marijuana business licenses. This move follows a slow start, with only about two dozen retailers operating since adult-use sales began last December. The application period will run until December 4, and licenses are expected to be awarded early next year.

    The Changing Landscape of Cannabis Product and Sourcing Choices

    According to the latest data from New Frontier, consumer behavior regarding the purchase of cannabis products is experiencing a notable shift. The data reveals that more consumers are opting to order their cannabis products from brick and mortar dispensaries, indicating a growing preference for in-person shopping experiences. In 2022, 34% of consumers chose physical dispensaries, and this figure has risen to 43% in 2023. Additionally, there has been a slight reduction in cannabis delivery, with 18% of consumers utilizing this option in 2022, which has decreased to 15% in 2023. This trend can be attributed to a post-COVID era where individuals feel more comfortable leaving their homes and seeking out physical retail experiences. In this article, we will explore the normalization of cannabis product and sourcing choices, and how these changes are shaping the industry.